Cargando…
A randomized double-blind controlled trial of the use of dydrogesterone in women with threatened miscarriage in the first trimester: study protocol for a randomized controlled trial
BACKGROUND: Miscarriage is a common complication of pregnancy occurring in 15–20 % of all clinically recognized pregnancies. Currently, there is still no good scientific evidence to support the routine use of progestogens for the treatment of threatened miscarriage because the existing studies were...
Autores principales: | Chan, Diana Man Ka, Cheung, Ka Wang, Yung, Sofie Shuk Fei, Lee, Vivian Chi Yan, Li, Raymond Hang Wun, Ng, Ernest Hung Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4989484/ https://www.ncbi.nlm.nih.gov/pubmed/27534747 http://dx.doi.org/10.1186/s13063-016-1509-8 |
Ejemplares similares
-
A systematic review of dydrogesterone for the treatment of threatened miscarriage
por: Carp, Howard
Publicado: (2012) -
The effects of dydrogesterone treatment on first-trimester aneuploidy screening markers and nuchal translucency in women with threatened miscarriage
por: Yıldız, Elif, et al.
Publicado: (2023) -
Randomized controlled trial of transcutaneous electrical nerve stimulation for pain relief during transvaginal oocyte retrieval using conscious sedation: study protocol for a randomized controlled trial
por: Wong, Queenie Ho Yan, et al.
Publicado: (2019) -
A randomized, double blinded, placebo controlled trial of oral dydrogesterone supplementation in the management of preterm labor
por: Areeruk, Wilasinee, et al.
Publicado: (2016) -
Progesterone for women with threatened miscarriage (STOP trial): a placebo-controlled randomized clinical trial
por: McLindon, Lucas A, et al.
Publicado: (2023)